Cargando…
COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
BACKGROUND: As of November 2020, severe acute respiratory syndrome coronavirus 2 has resulted in 55 million infections worldwide and more than 1.3 million deaths from coronavirus disease 2019 (COVID-19). Outcomes following severe acute respiratory syndrome coronavirus 2 infection in individuals with...
Autores principales: | Shields, Adrian M., Burns, Siobhan O., Savic, Sinisa, Richter, Alex G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Academy of Allergy, Asthma & Immunology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737531/ https://www.ncbi.nlm.nih.gov/pubmed/33338534 http://dx.doi.org/10.1016/j.jaci.2020.12.620 |
Ejemplares similares
-
Treatment of chronic or relapsing COVID-19 in immunodeficiency
por: Brown, Li-An K., et al.
Publicado: (2022) -
Impact of vaccination on hospitalization and mortality from COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
por: Shields, Adrian M., et al.
Publicado: (2022) -
Challenges in the Practice of Sexual Medicine in the Time of COVID-19 in the United Kingdom
por: Jacob, Louis, et al.
Publicado: (2020) -
Impact of COVID-19 on stroke admissions, treatments, and outcomes at a comprehensive stroke centre in the United Kingdom
por: Padmanabhan, Nishita, et al.
Publicado: (2020) -
Income and Career Concerns Among Emerging Adults From Finland,
Sweden, and the United Kingdom During COVID-19
por: Nuckols, Julia A., et al.
Publicado: (2023)